| Cancer chemotherapy MT Amjad, A Chidharla, A Kasi | 215 | 2020 |
| Kidney disease and COVID-19 disease severity—Systematic review and meta-analysis J Singh, P Malik, N Patel, S Pothuru, A Israni, RC Chakinala, MR Hussain, ... Clinical and experimental medicine 22 (1), 125-135, 2022 | 67 | 2022 |
| Sex-bias in COVID-19-associated illness severity and mortality in cancer patients: a systematic review and meta-analysis R Park, A Chidharla, K Mehta, W Sun, E Wulff-Burchfield, A Kasi EClinicalMedicine 26, 2020 | 41 | 2020 |
| Clinical outcome of ampullary carcinoma: single cancer center experience M Al-Jumayli, A Batool, A Middiniti, A Saeed, W Sun, R Al-Rajabi, ... Journal of oncology 2019 (1), 3293509, 2019 | 28 | 2019 |
| A case report of COVID-associated catastrophic antiphospholipid syndrome successfully treated with eculizumab A Chidharla, SB Syed, T Chatterjee, MD Tarantino Journal of Blood Medicine, 929-933, 2021 | 16 | 2021 |
| Cancer Chemotherapy. 2023 Feb 27 MT Amjad, A Chidharla, A Kasi StatPearls [Internet]. Treasure Island: StatPearls Publishing, 2023 | 12 | 2023 |
| Social media and professional development for oncology professionals A Chidharla, A Utengen, DJ Attai, EK Drake, GJ Van Londen, IM Subbiah, ... JCO oncology practice 18 (8), 566-571, 2022 | 12 | 2022 |
| Cancer prevalence in e-cigarette users: a retrospective cross-sectional NHANES study A Chidharla, K Agarwal, S Abdelwahed, R Bhandari, A Singh, R Rabbani, ... World journal of oncology 13 (1), 20, 2022 | 12 | 2022 |
| Cancer chemotherapy.[Updated 2022 Mar 3] MT Amjad, A Chidharla, A Kasi StatPearls [Internet]. Treasure Island: StatPearls Publishing, 2022 | 11 | 2022 |
| Cetuximab A Chidharla, M Parsi, A Kasi | 11 | 2017 |
| StatPearls: Treasure Island MT Amjad, A Chidharla, A Kasi FL, USA, 2023 | 10 | 2023 |
| Circulating tumor DNA as a minimal residual disease assessment and recurrence risk in patients undergoing curative-intent resection with or without adjuvant chemotherapy in … A Chidharla, E Rapoport, K Agarwal, S Madala, B Linares, W Sun, ... International journal of molecular sciences 24 (12), 10230, 2023 | 7 | 2023 |
| StatPearls A Chidharla, M Parsi, AC Kasi StatPearls Publishing: Treasure Island, FL, USA, 2023 | 6 | 2023 |
| Cancer, chemotherapy acral erythema (Palmarplantar erythrodysesthesia, palmoplantar erythrodysesthesia, hand-foot syndrome) A Chidharla, A Kasi StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2019 …, 2020 | 5 | 2020 |
| Chemotherapy acral erythema A Chidharla, T Kanderi, A Kasi | 5 | 2017 |
| Diagnostic accuracy of elastography and liver disease: a meta-analysis P Malik, S Pillai, K Agarwal, S Abdelwahed, R Bhandari, A Singh, ... Gastroenterology Research 15 (5), 232, 2022 | 4 | 2022 |
| A challenging case of heparin-induced skin necrosis without thrombocytopenia A Chidharla, EA Rapoport, N Naffakh, JC Roberts Blood Coagulation & Fibrinolysis 33 (2), 134-137, 2022 | 4 | 2022 |
| Oxaliplatin-associated sarcoid-like reaction masquerading as recurrent colon cancer SK Aedma, A Chidharla, S Kelting, A Kasi BMJ Case Reports CP 13 (9), e229548, 2020 | 4 | 2020 |
| Targeting germline or somatic DNA repair defects (beyond BRCA) in pancreatic cancer with niraparib: A phase II study (NIRA-PANC). A Kasi, J Dai, RMT Al-Rajabi, JC Baranda, A Saeed, P Chalise, E Carroll, ... Journal of Clinical Oncology 41 (16_suppl), 4156-4156, 2023 | 3 | 2023 |
| Phase Ib/IIa trial of CEND‐1 in combination with neoadjuvant FOLFIRINOX-based therapies in pancreatic, colorectal, and appendiceal cancers (CENDIFOX). A Kasi, H Jarvelainen, RMT Al-Rajabi, A Saeed, MA Phadnis, A Chidharla, ... Journal of Clinical Oncology 40 (16_suppl), TPS4195-TPS4195, 2022 | 3 | 2022 |
